PEG300

CAS No. 25322-68-3

PEG300( Polyethylene glycol 300 )

Catalog No. M22101 CAS No. 25322-68-3

PEG300 is a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PEG300
  • Note
    Research use only, not for human use.
  • Brief Description
    PEG300 is a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.
  • Description
    PEG300 is a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Polyethylene glycol 300
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    25322-68-3
  • Formula Weight
    300
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (333.33 mM; Need ultrasonic);H2O:50 mg/mL (166.67 mM)
  • SMILES
    OCCCCOC[H].[n]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 34-Diaminotoluene

    34-Diaminotoluene is a chemical compound.

  • MPEP

    MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM, exhibits no appreciable activity at mGlu1b/2/3/4a/7b/8a/6 receptors.

  • 3-Epiursolic acid

    3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.